Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-23-032703
Filing Date
2023-09-15
Accepted
2023-09-15 06:05:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 770296
2 form424b5_001.jpg GRAPHIC 9324
3 form424b5_002.jpg GRAPHIC 240305
4 form424b5_003.jpg GRAPHIC 32935
  Complete submission text file 0001493152-23-032703.txt   1160592
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

EIN.: 000000000
Type: 424B5 | Act: 33 | File No.: 333-272516 | Film No.: 231256626
SIC: 2836 Biological Products, (No Diagnostic Substances)